S Kant India Private Limited
About S Kant India Private Limited
Data last updated:
S Kant India Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 January 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2023PTC397388. Its GSTIN is 29ABKCS1738H1ZZ (Karnataka).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mahesh Kantilal Shah and Rohan Mahesh Shah.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flr – G 15 Mehta Mahal P L Khandke Marg Mathew Road Opera House Girgaon, Mumbai, Maharashtra, India – 400004.
As per the financials filed for FY 2025, the company reported a revenue of ₹73.61 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹49.71 Lakh (net margin 0.7%) and EBITDA of ₹84.59 Lakh (EBITDA margin 1.1%).
As per MCA filings, the company has open charges of ₹5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
S Kant India Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressFlr – G 15 Mehta Mahal P L Khandke Marg Mathew Road Opera House Girgaon, Mumbai, Maharashtra, India – 400004
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of S Kant India is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of S Kant India Private Limited, buy the company report.
Financials of S Kant India Private Limited
FY 2025 filings availableS Kant India Private Limited reported revenue of ₹73.61 Cr (up 7272% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹84.59 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹49.71 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.1% | ||
| Net Profit Margin | 0.7% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of S Kant India Private Limited, buy the company report.
Board of directors of S Kant India Private Limited
S Kant India has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahesh Kantilal Shah Also directs: Shroff Pharma LLP, Skites Pharma Private Limited, Ashok GNXT Pharma Private Limited and 1 more | Director | 11 Jan 2023 | 3 Years 9 Months | Current |
| Rohan Mahesh Shah | Director | 11 Jan 2023 | 3 Years 9 Months | Current |
| Samir Jayantilal Shah | Director | 11 Jan 2023 | 3 Years 9 Months | Current |
| Yusuke Kumaki Also directs: Skites Pharma Private Limited, Ashok GNXT Pharma Private Limited | Director | 27 Jun 2025 | 1 Years 4 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Apr 2024 | 100914750 | Hdfc Bank Limited | ₹5 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving S Kant India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for S Kant India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
S Kant India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29ABKCS1738H1ZZ | Karnataka | Active | 27 Feb 2024 |
To see the full GST registrations and return filing status of S Kant India Private Limited, buy the company report.
Recent activity
S Kant India Private Limited has 6 board changes on record since 2023: 5 appointments and 1 cessation. The latest: Eishi Takahide Maekawa ceased to be Director on 27 Jun 2025.
Frequently asked questions
S Kant India is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 January 2023 (3+ years old) and is registered under CIN U24290MH2023PTC397388.
S Kant India has 4 current directors:
- Mahesh Kantilal Shah - Director
- Rohan Mahesh Shah - Director
- Samir Jayantilal Shah - Director
- Yusuke Kumaki - Director
The latest financial statements of S Kant India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of S Kant India is 29ABKCS1738H1ZZ, registered in Karnataka.
The CIN (Corporate Identification Number) of S Kant India is U24290MH2023PTC397388. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
S Kant India was incorporated on 11 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
Eishi Takahide Maekawa ceased to be Director on 27 Jun 2025. Yusuke Kumaki was appointed as Director on 27 Jun 2025. Eishi Takahide Maekawa was appointed as Director on 11 Jan 2023. S Kant India has 6 board changes on record in total.
The registered office of S Kant India is at Flr – G 15 Mehta Mahal P L Khandke Marg Mathew Road Opera House Girgaon, Mumbai, Maharashtra, India – 400004.
S Kant India operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
S Kant India has open charges of ₹5 Cr and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
